Opsonic Property of Multiple Myeloma Serum

R. P. May, J. A. Barnett, J. W. Smith, E. P. Frenkel, J. P. Sanford

Research output: Contribution to journalArticle

Abstract

The opsonic activity of serum from 7 patients with multiple myeloma was studied in a phagocytic system employing human leucocytes and a strain of E. coli 0-4. It was demonstrated that these patients have sufficient heat-labile opsonin to promote phagocytosis and intracellular killing of the ingested organisms. The presence of myeloma protein did not interfere with this property.

Original languageEnglish (US)
Pages (from-to)1293-1297
Number of pages5
JournalProceedings of the Society for Experimental Biology and Medicine
Volume125
Issue number4
DOIs
StatePublished - Sep 8 1967

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Opsonic Property of Multiple Myeloma Serum'. Together they form a unique fingerprint.

  • Cite this

    May, R. P., Barnett, J. A., Smith, J. W., Frenkel, E. P., & Sanford, J. P. (1967). Opsonic Property of Multiple Myeloma Serum. Proceedings of the Society for Experimental Biology and Medicine, 125(4), 1293-1297. https://doi.org/10.3181/00379727-125-32339